Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059926) titled 'Clinical Study of Restless Legs Syndrome in Patients with End-Stage Renal Disease' on Dec. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Division of Nephrology and Dialysis Center,
Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan
Condition:
Condition - Restless Legs Syndrome
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the clinical characteristics of restless legs syndrome in patients with end-stage renal failure.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients currently receiving dialysis therapy (hemodialysis or peritoneal dialysis) at Fukuoka Red Cross Hospital, Maeda Hospital, and Hirakawa Clinic.
Key exclusion criteria - Patients who declined to participate in this study, and patients unable to complete the questionnaire
Target Size - 360
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 07 Day
Date of IRB - 2025 Year 11 Month 27 Day
Anticipated trial start date - 2025 Year 12 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068537
Disclaimer: Curated by HT Syndication.
